Home » Topics » Regulatory

Regulatory
RSS

FDA approves Xerava to treat complicated intra-abdominal infections

Aug. 28, 2018

Xarelto receives approval in the E.U. for the treatment of patients with artery disease

Aug. 27, 2018

FDA approves Inveltys for post-operative inflammation and pain

Aug. 24, 2018

FDA approves Diacomit for seizures associated with Dravet syndrome

Aug. 24, 2018

FDA approves Takhzyro for prevention of HAE attacks

Aug. 24, 2018

Ono announces new Japanese approvals for Opdivo

Aug. 22, 2018

Lenvatinib approved in the U.S. for unresectable hepatocellular carcinoma

Aug. 17, 2018

Kalydeco approved in U.S. for cystic fibrosis in patients aged 12 to < 24 months

Aug. 16, 2018

FDA approves The Population Council's 1-year contraceptive Annovera

Aug. 13, 2018

Alnylam's RNAi therapeutic Onpattro for polyneuropathy of hATTR amyloidosis receives first approval

Aug. 13, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...